跳至主要内容
临床试验/NCT03288909
NCT03288909Unknown不适用

Ultra High Field Magnetic Resonance Imaging as a Biomarker for Premotor Parkinson's Disease

Oregon Health and Science University1 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2015年9月最近更新:
适应症

试验速览

阶段
不适用
入组人数
18
试验地点
1
主要终点
Quantitative signal analysis of nigrosome 1

研究概览

简要总结

This is a prospective observational study investigating the utility of 7 Tesla MRI to quantify nigrosome1 signal in a cohort of individuals with recent onset Parkinson's disease and in at-risk cohorts at a premotor state of Parkinson's disease.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Idiopathic Parkinson's disease within 1 year of motor symptom onset. Idiopathic REM sleep behavior disorder without signs/symptoms of Parkinson's disease.
  • Age-matched controls.

排除标准

  • Atypical Parkinsonism
  • Contraindications for MRI

结局指标

主要结局

Quantitative signal analysis of nigrosome 1

时间窗: 1 year

次要结局

  • Change in quantitative signal analysis of nigrosome 1(3 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Matthew Brodsky

Associate Professor of Neurology

Oregon Health and Science University

研究点 (1)

Loading locations...

相似试验

Ultra High Field Magnetic Resonance Imaging as a... | 临床试验